Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

ConditionsUterine Bleeding Uterine Cancer Uterine Neoplasms Endometrial Cancer Endometrial Hyperplasia Endometrial Intraepithelial Neoplasia Menstrual Cycle Reproductive Endocrinology

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age35+

SponsorUniversity of British Columbia

About this trial

The investigators will obtain urine hormone results and validated menstrual bleeding score from people experiencing abnormal uterine bleeding. The investigators will evaluate satisfaction and ease of use of Mira monitor. The investigators will measure recruitment rate, attrition and cycle collection completeness of data. The investigators will evaluate menstrual health literacy at baseline and at the conclusion of the study.

Eligibility criteria

Qualifiers

35 years and older

Have experienced AUB

Disqualifiers

Currently pregnant or become pregnant during their participation

Previous surgeries impairing the menstrual cycle (e.g. hysterectomy, bilateral oophorectomy)

Currently or in the previous 3 months on medications that are known to impair or stimulate ovulation (e.g. oral contraceptives, ovulation stimulants, hormone replacement, etc.)

Trial design

Treatments tested in this trial

Not listed

Trial groups

50 Participants

are grouped into 1 trial group

Locations

Vancouver General Hospital Research PavillionV5Z 1N1, VancouverBritish Columbia, Canada

Sponsors and collaborators

University of British Columbia

Lead sponsor

Source ClinicalTrials.gov